Pretreatment with granulocyte-colony stimulating factor decreases lipopolysaccharide-induced interferon-γ production in mice in association with the production of interleukin-18

Cytokine

Volumn 25, Issue 3, 2004, Pages 119-126

  Shaklee, Christine L ^a   Guo, Jane ^a   Faggioni, Raffaella ^a   Fantuzzi, Giamila ^b   Senaldi, Giorgio ^a,c  

^a AMGEN INC   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c Abgenix Inc   (United States)

Author keywords

G CSF; IFN ; IL 18; LPS; Neutrophils

Indexed keywords

ANTIBODY; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 18; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROTEIN P40; PROTEIN P70; RIBONUCLEASE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; INFLAMMATION; LIVER LEVEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RIBONUCLEASE PROTECTION ASSAY; RNA ANALYSIS; SPLEEN; TISSUE LEVEL;

EID: 0346040318     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2003.10.007     Document Type: Article

References (47)

1. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P. Definitions of sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 101:1992;1644-1655.
2. Michie H.R., Manogue K.R., Spriggs D.R., Revhaug A., O'Dwyer S., Dinarello C.A., et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med. 318:1988;1481-1486.
3. Calandra T., Gerain J., Heumann D., Baumgartner J.D., Glauser M.P. High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. Am J Med. 91:1991;23-29.
4. Kuhns D.B., Gregory Alvord J., Gallin J.I. Increased circulating cytokines, cytokine antagonists, and E-selectin after intravenous administration of endotoxin in humans. J Infect Dis. 171:1995;145-152.
5. Gardlund B., Sjolin J., Nilsson A., Roll M., Wickerts C.-J., Wretlind B. Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. J Infect Dis. 172:1995;296-301.
6. Marchant A., Deviere J., Byl B., de Groote D., Vincenti J.L., Goldman M. Interleukin-10 production during septicaemia. Lancet. 343:1994;707-708.
7. Derkx B., Marchant A., Goldman M., Bijlmer R., van Deventer S. High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock. J Infect Dis. 171:1995;229-232.
8. Aderka D.J., Le J., Vilcek J. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J Immunol. 143:1989;3517-3523.
9. Marchant A., Bruyns C., Vandenabeele P., Ducarne M., Gerard C., Delvaux A., et al. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol. 24:1994;1167-1171.
10. Bone R.C. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med. 24:1996;1125-1128.
11. Bone R.C. The pathogenesis of sepsis. Ann Intern Med. 115:1991;457-469.
12. Demetri G.D., Griffin J.D. Granulocyte-colony stimulating factor and its receptor. Blood. 78:1991;2791-2808.
13. Densen P., Clark R.A., Neuseef W.M. Granulocytic phagocytes. Mandell G.L., Bennett J.E., Dolin R. Principles and practice of infectious diseases. 1995;78-95 Churchill Livingstone, New York.
14. Dale D.C., Conrad Liles W., Summer W.R., Nelson S. Granulocyte colony-stimulating factor - role and relationships in infectious diseases. J Infect Dis. 172:1995;1061-1075.
15. Hartung T., Doecke W.-D., Gantner F., Krieger G., Sauer A., Stevens P., et al. Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood. 85:1995;2482-2489.
16. Pollmacher T., Korth C., Mullington J., Schreiber W., Sauer J., Vedder H., et al. Effects of granulocyte colony-stimulating factor on plasma cytokine and cytokine receptor levels and the in vivo host response to endotoxin in healthy men. Blood. 87:1996;900-905.
17. Toki S., Hiromatsu K., Aoki Y., Makino M., Yoshikai Y. Protective effects of granulocyte colony-stimulating factor on endotoxin shock in mice with retrovirus-induced immunodeficiency syndrome. Cytokine. 9:1997;781-786.
18. Villa P., Shaklee C.L., Meazza C., Agnello D., Ghezzi P., Senaldi G. Granulocyte colony-stimulating factor and antibiotics in the prophylaxis of a murine model of polymicrobial peritonitis and sepsis. J Infect Dis. 178:1998;471-477.
19. Weiss M., Moldawer L.L., Schneider E.M. Granulocyte colony-stimulating factor to prevent the progression of systemic nonresponsiveness in systemic inflammatory response syndrome and sepsis. Blood. 93:1999;425-439.
20. Morrison D.C., Ryan J.L. Endotoxins and disease mechanisms. Annu Rev Med. 93:1987;417-432.
21. Watson R.W., Redmond H.P., Bouchier H.D. Role of endotoxin in mononuclear phagocyte-mediated inflammatory responses. J Leukoc Biol. 56:1994;95-103.
22. Heinzel F.P., Rerko R.M., Ling P., Hakimi J., Schoenhaut D.S. Interleukin-12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon. Infect Immun. 62:1994;4244-4249.
23. Okamura H., Tsutsi H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature. 378:1995;88-91.
24. Beutler B., Milsark W., Cerami A.C. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effects of endotoxin. Science. 229:1985;869-871.
25. Billiau A., Heremans H., Vandekerckhove F., Dillen C. Anti-interferon-gamma antibody protects mice against the generalized Shwartzman reaction. Eur J Immunol. 17:1987;1851-1854.
26. Barton B.E., Jackson J.V. The protective role of IL-6 in a septic shock model. Infect Immun. 61:1993;1496-1499.
27. Gerard C., Bruyns C., Merchant A., Abramowicz D., Vandenabeele P., Delvaux A., et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med. 177:1993;547-550.
28. Krenger W., Hill G.R., Ferrara J.L.M. Cytokine cascades in acute graft-versus-host disease. Transplantation. 64:1997;553-558.
29. Dubravec D.B., Spriggs D.R., Mannick J.A., Rodrick M.L. Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor alpha. Proc Natl Acad Sci U S A. 87:1990;6758-6761.
30. Kornbluth R.S., Edgington T.S. Tumor necrosis factor production by human monocytes is a regulated event: induction of TNF-alpha-mediated cellular cytotoxicity by endotoxin. J Immunol. 137:1986;2585-2591.
31. Kitabayashi A., Hirokawa M., Hatano Y., Lee M., Kuroki J., Niitsu H., et al. Granulocyte colony-stimulating factor downregulates allogeneic immune responses by posttranscriptional inhibition of tumor necrosis factor-α production. Blood. 86:1995;2220-2227.
32. Terashima T., Soejima K., Waki Y., Nakamura H., Fujishima S., Suzuki Y., et al. Neutrophils activated by granulocyte colony-stimulating factor suppress tumor necrosis factor-α release from monocytes stimulated by endotoxin. Am J Respir Cell Mol Biol. 13:1995;69-73.
33. Ceuppens J.L., Baroja M.L., Lorre K., Van Damme J., Billiau A. Human T cell activation with phytohemagglutinin. The function of IL-6 as an accessory signal. J Immunol. 141:1988;3868-3874.
34. Cicco N.A., Lindemann A., Content J., Vandenbussche P., Luebbert M., Gauss J., et al. Inducible production of interleukin-6 by human polymorphonuclear neutrophils: role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha. Blood. 75:1990;2049-2052.
35. + T helper subset selection in mice with candidiasis. J Immunol. 158:1997;2356-2362.
36. de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., de Vries J. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med. 174:1991;1209-1220.
37. Fantuzzi G., Reed D.A., Dinarello C.A. IL-12-induced IFN-gamma is dependent on caspase-1 processing of the IL-18 precursor. J Clin Invest. 104:1999;761-767.
38. Gorgen I., Hartung T., Leist M., Niehorster M., Tiegs G., Uhlig S., et al. Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-α J Immunol. 149:1992;918-924.
39. Pajkrt D., Manten A., van der Poll T., Tiel-van Buul M.M.C., Jansen J., Wouter ten Cate J., et al. Modulation of cytokine release and neutrophil function by granulocyte colony-stimulating factor during endotoxemia in humans. Blood. 90:1997;1415-1424.
40. Hartung T. Anti-inflammatory effects of granulocyte colony-stimulating factor. Curr Opin Hematol. 5:1998;221-225.
41. Pan L., Delmonte J. Jr., Jalonen C.K., Ferrara J.L.M. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood. 86:1995;4422-4429.
42. Mielcarek M., Graf L., Johnson G., Torok-Storb B. Production of interleukin-10 by granulocyte colony-stimulating factor-mobilized blood products: a mechanism for monocyte-mediated suppression of T-cell proliferation. Blood. 92:1998;215-222.
43. Cannon J.G., Rompkins R.G., Gelfand J.A., Michie H.R., Stanford G.G., van der Meer J.W.M., et al. Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis. 161:1990;79-84.
44. Ulich T.R., Guo K., Remick D., Del Castillo J., Yin S. Endotoxin-induced cytokine gene expression in vivo III. IL-6 mRNA and serum protein expression and the in vivo hematologic effects of IL-6 . J Immunol. 146:1991;2316-2323.
45. Durez P., Abramowicz D., Gerard C., Van M.M., Amraoui Z., Dubois C., et al. In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin A. J Exp Med. 177:1993;551-555.
46. Wysocka M., Kubin M., Vieira L.Q., Ozmen L., Garotta G., Scott P., et al. Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur J Immunol. 25:1995;672-676.
47. Netea M.G., Fantuzzi G., Kullberg B.J., Stuyt R.J., Pulido E.J., McIntyre R.C. Jr., et al. Neutralization of IL-18 reduces neutrophil tissue accumulation and protects mice against lethal Escherichia coli and Salmonella typhimurium endotoxemia. J Immunol. 164:2000;2644-2649.